CIPLA LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,398 INR | +3.82% |
|
+1.67% | +12.19% |
| 12:28pm | Indian Equities End Higher Midweek as Iran-Israel Conflict Subsides | MT |
| Apr. 18 | India's Biocon developing its own version of Wegovy, clinical trial likely next year | RE |
Business Summary
Net sales by source of income break down between sale of products (96.9%) and services (3.1%).
Net sales are distributed geographically as follows: India (39.4%), the United States (18.5%), South Africa (17%) and other (25.1%).
Number of employees: 32,323
Sales per Business
| INR in Million | 2022 | Weight | 2023 | Weight | Delta |
|---|---|---|---|---|---|
Pharmaceuticals
96.7
%
| 213,513 | 98.1 % | 219,994 | 96.7 % | +3.04% |
New Ventures
4.6
%
| 5,315 | 2.4 % | 10,548 | 4.6 % | +98.46% |
Inter Segment
-1.3
%
| -1,194 | -0.5 % | -3,012 | -1.3 % | +152.13% |
Sales per region
| INR in Million | 2022 | Weight | 2023 | Weight | Delta |
|---|---|---|---|---|---|
India
43.4
%
| 98,275 | 45.2 % | 98,687 | 43.4 % | +0.42% |
United States
26.0
%
| 44,314 | 20.4 % | 59,087 | 26.0 % | +33.34% |
Rest of the World
20.4
%
| 48,715 | 22.4 % | 46,407 | 20.4 % | -4.74% |
South Africa
10.3
%
| 26,330 | 12.1 % | 23,351 | 10.3 % | -11.31% |
Managers
| Managers | Title | Age | Since |
|---|---|---|---|
Umang Vohra
CEO | Chief Executive Officer | 52 | 15-09-30 |
Ashish Adukia
DFI | Director of Finance/CFO | - | 22-08-15 |
Geena Malhotra
CTO | Chief Tech/Sci/R&D Officer | - | 85-12-31 |
| Chief Tech/Sci/R&D Officer | - | 19-12-31 | |
Jaideep Gogtay
CTO | Chief Tech/Sci/R&D Officer | 58 | 94-08-31 |
Rajendra Chopra
CMP | Compliance Officer | - | 17-02-08 |
| Director/Board Member | 83 | 77-08-15 | |
Dinesh Jain
PRN | Corporate Officer/Principal | - | 12-04-08 |
Deepak Viegas
AUD | Comptroller/Controller/Auditor | - | 17-01-31 |
Raju Mistry
HRO | Human Resources Officer | 60 | 19-03-31 |
Members of the board
| Members of the board | Title | Age | Since |
|---|---|---|---|
Ashok K. Sinha
BRD | Director/Board Member | 72 | 13-07-15 |
| Chairman | 87 | 72-07-20 | |
| Director/Board Member | 83 | 77-08-15 | |
| Director/Board Member | 70 | 14-07-24 | |
Umang Vohra
CEO | Chief Executive Officer | 52 | 15-09-30 |
Punita Lal
BRD | Director/Board Member | 60 | 14-11-12 |
| Director/Board Member | 67 | 10-11-11 | |
Robert Stewart
BRD | Director/Board Member | 56 | 21-05-13 |
| Director/Board Member | 69 | 21-06-29 | |
| Director/Board Member | 48 | - |
Share class
| Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
|---|---|---|---|---|---|
| Stock A | 1 | 807,394,968 | 520,684,537 ( 64.49 %) | 0 | 64.49 % |
Holdings
| Name | Equities | % | Valuation |
|---|---|---|---|
| 1,869,170,684 | 51.18% | 25,252,496 $ |
Company contact information
Cipla Ltd.
Cipla House, Peninsula Business Park Ganpatrao Kadam Marg
400013, Mumbai
+91 22 2482 6000
http://www.cipla.com
Group companies
| Name | Category and Sector |
|---|---|
Meditab Specialities Pvt Ltd.
 Meditab Specialities Pvt Ltd. Pharmaceuticals: MajorHealth Technology Meditab Specialities Pvt Ltd. provides pharmaceutical services. Its specialized in manufacturing facilities,approved by W.H.O. to manufacture dosage forms like Tablets, Capsules, Inhalers, Powders,etc they are contributing to various Pharmacopoeias like EP, BP and USP. The company is headquartered at India. |
Pharmaceuticals: Major
|
InvaGen Pharmaceuticals, Inc.
 InvaGen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology InvaGen Pharmaceuticals, Inc. manufactures and distributes generic prescription medicines. It develops and markets generic pharmaceuticals with focus on therapeutic areas including, cardiovascular, anti-infective, CNS, anti-inflammatory, anti-diabetic and anti-depressants. The company was founded by Sudhakar Vidiyala, Madhava U. Reddy and Amar Reddy in 2003 and is headquartered in Hauppauge, NY. |
Pharmaceuticals: Major
|
Medispray Laboratories Pvt Ltd.
 Medispray Laboratories Pvt Ltd. Pharmaceuticals: MajorHealth Technology Part of Cipla Ltd., Medispray Laboratories Pvt Ltd. is a pharmaceutical company founded in 1992. The private company is based in Goa, India. The Indian company manufactures and distributes pharmaceutical products. |
Pharmaceuticals: Major
|
Jay Precision Pharmaceuticals Pvt Ltd.
 Jay Precision Pharmaceuticals Pvt Ltd. Pharmaceuticals: MajorHealth Technology Part of Cipla Ltd., Jay Precision Pharmaceuticals Pvt Ltd. is a pharmaceutical company that specializes in manufacturing respiratory devices. The private company is based in Mumbai, India. The company was founded in 2012. Jay Precision Pharmaceuticals was acquired by Cipla Ltd. on February 12, 2015 for $15.42 million. |
Pharmaceuticals: Major
|
Cipla Health Ltd.
 Cipla Health Ltd. Pharmaceuticals: MajorHealth Technology Cipla Health Ltd. develops drugs. It offers products under the brand name include Nicotex, Active immuno boosters, Active women daily calcium and cofsils lozenge, Cofsils cough drops, Cofsils natural ough syrup, Nicogum and Fibocare. The company was founded in August 2015 and is headquartered in Mumbai, India. |
Pharmaceuticals: Major
|
Goldencross Pharma Pvt Ltd.
| |
Sitec Labs Ltd.
| |
Cipla Pharmaceuticals Ltd.
| |
Cipla (EU) Ltd.
 Cipla (EU) Ltd. Pharmaceuticals: MajorHealth Technology Cipla (EU) Ltd. engages in the trading and holding of marketing registrations for various pharmaceutical products. The company was founded on August 16, 2002 and is headquartered in Esher, the United Kingdom. |
Pharmaceuticals: Major
|
Sector
Sales per Business
Sales per region
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +12.19% | 13.05B | |
| +17.97% | 42.77B | |
| +20.21% | 22.23B | |
| +12.27% | 14.44B | |
| +35.45% | 11.59B | |
| -8.80% | 6.95B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +5.03% | 4.97B | |
| -6.46% | 4.6B |
- Stock Market
- Equities
- CIPLA Stock
- Company Cipla Limited
